233 related articles for article (PubMed ID: 23259199)
1. Reexamination of field-directed therapy for actinic keratosis.
Rosen T
Cutis; 2012 Oct; 90(4):163-5. PubMed ID: 23259199
[No Abstract] [Full Text] [Related]
2. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
Berman B; Cohen DE; Amini S
Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
[TBL] [Abstract][Full Text] [Related]
3. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
Lee AD; Jorizzo JL
Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
[TBL] [Abstract][Full Text] [Related]
4. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents.
Berman B; Cohen DE; Amini S
Cutis; 2012 May; 89(5):241-50. PubMed ID: 22768439
[TBL] [Abstract][Full Text] [Related]
5. Actinic keratosis: facts and controversies.
Ko CJ
Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
[TBL] [Abstract][Full Text] [Related]
6. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
7. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
Basset-Seguin N
Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
9. [Actinic keratosis: the art of doing nothing].
Eekhof JA
Ned Tijdschr Geneeskd; 2013; 157(11):A5363. PubMed ID: 23484509
[TBL] [Abstract][Full Text] [Related]
10. New wine in old bottles: the coming deluge of aggressive cutaneous cancers and precancers.
Wassef C; Lee B; Lambert PC; Patel L; Lambert WC
Skinmed; 2014; 12(3):183-5. PubMed ID: 25134315
[No Abstract] [Full Text] [Related]
11. Therapeutic update on actinic keratosis.
Sarnoff DS
J Drugs Dermatol; 2014 Jul; 13(7):785-6. PubMed ID: 25007359
[No Abstract] [Full Text] [Related]
12. Actinic keratosis: new concepts and therapeutic approaches for an ancestral condition.
Alomar A
Actas Dermosifiliogr; 2014 Nov; 105(9):809-12. PubMed ID: 25060321
[No Abstract] [Full Text] [Related]
13. Ingenol Mebutate and the Treatment of Actinic Keratosis.
Heron CE; Feldman SR
J Drugs Dermatol; 2021 Jan; 20(1):102-104. PubMed ID: 33400406
[TBL] [Abstract][Full Text] [Related]
14. [Actinic keratoses].
Hommel T; Szeimies RM
Hautarzt; 2016 Nov; 67(11):867-875. PubMed ID: 27613022
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for actinic keratosis.
Ulrich M; Drecoll U; Stockfleth E
Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
[TBL] [Abstract][Full Text] [Related]
16. Current management of actinic keratoses.
Shoimer I; Rosen N; Muhn C
Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
[TBL] [Abstract][Full Text] [Related]
17. [When and why treat actinic keratoses?].
Wulf HC
Ugeskr Laeger; 2014 Feb; 176(6A):V07130448. PubMed ID: 25347437
[TBL] [Abstract][Full Text] [Related]
18. Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
Peserico A; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Peris K; Pimpinelli N
G Ital Dermatol Venereol; 2013 Oct; 148(5):515-24. PubMed ID: 24005145
[No Abstract] [Full Text] [Related]
19. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
Abramovits W; Oquendo M; Vincent KD; Gupta AK
Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
[No Abstract] [Full Text] [Related]
20. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
Bettencourt MS
J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
